S&P 500

5.267,84

-0,74%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Biodelivery Sciences International (MM) (BDSIW)
Biodelivery Sciences International (MM) (BDSIW) Notícias

BDSIW

Biodelivery Sciences International (MM) (BDSIW)

Biodelivery Sciences International (MM)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:BDSIW

1

Data	Hora	Fonte	Título	Código	Companhia
08/11/2005	12:44	Business Wire	BDSI Announces Supply Agreement Relating to BEMA(TM) Fentanyl; Agreement with Aveva Drug Delivery Systems a Key Milestone as BDS	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
01/11/2005	10:30	Business Wire	BDSI Prepares For Phase III with BEMA(TM) Fentanyl Following Positive Results of Comparative Pharmacokinetic Study	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
05/10/2005	12:13	Business Wire	BDSI Closes Public Offering of 4.4 Million Shares	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
30/09/2005	09:04	Business Wire	BDSI Prices Public Offering of 4.4 Million Shares	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
16/09/2005	17:30	Business Wire	BDSI Announces Director Resignations; Donald Ferguson and Alan Pearce Resign So That Company Can Comply with Nasdaq Independence	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
20/07/2005	11:28	Business Wire	BDSI Announces Acceptance of Emezine(R) NDA for Review By FDA	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
18/07/2005	12:03	Business Wire	BDSI Secures $7 Million Financing Commitment For Development of BEMA(TM) Fentanyl; Funding Targeted for Phase III Trials of Canc	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
03/06/2005	08:00	Business Wire	BDSI Secures Additional $2.5 Million Financing With Laurus Master Fund	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
02/05/2005	08:30	Business Wire	BDSI Announces Submission of NDA for Emezine; First Transmucosal Product for the Treatment of Nausea and Vomiting	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
12/11/2004	19:37	PR Newswire (US)	BDSI Reports Financial Results for the Third Quarter Ended September 30, 2004	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
13/04/2004	13:00	PR Newswire (US)	BioDelivery Sciences International, Inc. Announces Licensing of Its Topical BioNasal (TM) Amphotericin B for Chronic Sinusitis	NASDAQ:BDSIW
06/04/2004	09:00	PR Newswire (US)	BioDelivery Sciences International, Inc. Reports 2003 Results	NASDAQ:BDSIW	Biodelivery Sciences International (MM)